SCHEMBL21998487

SCHEMBL21998487

O=C(/C=C/c1ccccc1)Nc1ccc(/C=C/c2ccc3c(c2)OCO3)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.76
KDM4E B2RXH2 8/20 0.76
SMN1; SMN2 Q16637 8/20 0.71
ALDH1A1 P00352 6/20 0.71
MEN1 O00255 6/20 0.71
KMT2A Q03164 6/20 0.71
RAB9A P51151 5/20 0.71
NPC1 O15118 4/20 0.71
POLB P06746 1/20 0.71
PKM P14618 1/20 0.66
TRPV1 Q8NER1 2/20 0.64
HPGD P15428 3/20 0.63
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP2C19 P33261 1/20 0.63
EPHX2 P34913 1/20 0.62
LMNA P02545 1/20 0.62
MAPK1 P28482 1/20 0.62
TOP2A P11388 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9911665 0.94 KDM4E (0.77) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1
SCHEMBL21998490 0.89 TRPV1 (0.80) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1
SCHEMBL21996664 0.89 KDM4E (0.74) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1
SCHEMBL21998488 0.89 KDM4E (0.78) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1
SCHEMBL109258 0.88 MAPT (0.81) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1
SCHEMBL18993423 0.87 KDM4E (0.79) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1
SCHEMBL22510789 0.87 KDM4E (0.79) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1
SCHEMBL21996663 0.86 KDM4E (0.64) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1
SCHEMBL95349 0.86 KDM4E (0.77) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1
SCHEMBL18027733 0.86 KDM4E (0.81) MAPTKDM4ESMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829466-B2 Stilbene derivative and preparation method thereof BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-11-10 US disclosed
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829466-B2 Stilbene derivative and preparation method thereof STS, F12, GLB1 MAPT 3955/4885KDM4E 4389/4885SMN1; SMN2 3805/4885
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF STS, F12, STK38L MAPT 3976/4885KDM4E 4442/4885SMN1; SMN2 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.